Medicure, Inc. (NASDAQ:MCUJF) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Medicure, Inc.

BRIEF

published on 05/28/2024 at 23:05, 5 months 23 days ago

Medicure Reports Financial Results for Q1 2024 and Director Election Results

Financial Results Director Election Q1 2024 Medicure
PRESS RELEASE

published on 05/28/2024 at 23:00, 5 months 23 days ago

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed

Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
BRIEF

published on 04/23/2024 at 23:05, 6 months 27 days ago

Medicure Receives FDA Fast Track Designation for MC-1 Treatment for PNPO Deficiency

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency
PRESS RELEASE

published on 04/23/2024 at 23:00, 6 months 27 days ago

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Medicure Inc. receives FDA Fast Track designation for MC-1 to treat PNPO deficiency seizures, a serious condition. Rare Pediatric Disease and Orphan Drug designations granted

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency Seizures
BRIEF

published on 04/08/2024 at 23:05, 7 months 12 days ago

Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance

Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 04/08/2024 at 23:00, 7 months 12 days ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
Medicure Inc. reports results from operations for the quarter and year ended December 31, 2023. Net revenue, EBITDA, and financial highlights disclosed

Financial Results EBITDA Quarterly Report Medicure Inc. Revenue Analysis
BRIEF

published on 04/05/2024 at 00:05, 7 months 16 days ago

Medicure Inc. to Announce 2023 Financial Results in Upcoming Conference Call

Financial Results Conference Call Pharmaceutical Industry Medicure Inc. 2023 Year End
PRESS RELEASE

published on 04/05/2024 at 00:00, 7 months 16 days ago

Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
Medicure Inc. to present 2023 Year End Financial Results on April 9, 2024, focusing on pharmaceuticals and healthcare products. Conference call details provided

Conference Call Pharmaceuticals Medicure Inc. Healthcare Products 2023 Year End Financial Results
PRESS RELEASE

published on 12/05/2023 at 23:00, 11 months 15 days ago

Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
Medicure Inc. announces a partnership with TheracosBio through Marley Drug to distribute BRENZAVVY, a new diabetes drug, at an affordable cash price, aiming to improve patient care in the US

Medicure Inc. TheracosBio BRENZAVVY Diabetes Drug Marley Drug
PRESS RELEASE

published on 11/23/2023 at 23:00, 11 months 27 days ago

Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

Accesswire

Published on 11/21/2024 at 13:30, 35 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 35 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 50 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 30 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 50 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 58 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 5 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 7 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 45 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE